GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kunming Longjin Pharmaceutical Co Ltd (SZSE:002750) » Definitions » Median PS Value

Kunming Longjin Pharmaceutical Co (SZSE:002750) Median PS Value : ¥0.00 (As of May. 24, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Kunming Longjin Pharmaceutical Co Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Kunming Longjin Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.228. Kunming Longjin Pharmaceutical Co's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is ¥0.00.

As of today (2024-05-24), Kunming Longjin Pharmaceutical Co's share price is ¥3.04. Kunming Longjin Pharmaceutical Co's Median PS Value is ¥0.00. Therefore, Kunming Longjin Pharmaceutical Co's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Kunming Longjin Pharmaceutical Co's Median PS Value or its related term are showing as below:

SZSE:002750's Price-to-Median-PS-Value is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.835
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Kunming Longjin Pharmaceutical Co Median PS Value Historical Data

The historical data trend for Kunming Longjin Pharmaceutical Co's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kunming Longjin Pharmaceutical Co Median PS Value Chart

Kunming Longjin Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Kunming Longjin Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Kunming Longjin Pharmaceutical Co's Median PS Value

For the Drug Manufacturers - Specialty & Generic subindustry, Kunming Longjin Pharmaceutical Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kunming Longjin Pharmaceutical Co's Price-to-Median-PS-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kunming Longjin Pharmaceutical Co's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Kunming Longjin Pharmaceutical Co's Price-to-Median-PS-Value falls into.



Kunming Longjin Pharmaceutical Co Median PS Value Calculation

Kunming Longjin Pharmaceutical Co's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=0.228*0
=0.00

10-Year Median PS Ratio is 0.
Kunming Longjin Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.228.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kunming Longjin Pharmaceutical Co  (SZSE:002750) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Kunming Longjin Pharmaceutical Co's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=3.04/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kunming Longjin Pharmaceutical Co Median PS Value Related Terms

Thank you for viewing the detailed overview of Kunming Longjin Pharmaceutical Co's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Kunming Longjin Pharmaceutical Co (SZSE:002750) Business Description

Traded in Other Exchanges
N/A
Address
789 Lanmao Road, High-tech Zone, Majinpu, Kunming, CHN, 650503
Kunming Longjin Pharmaceutical Co Ltd is a pharmaceutical company. It develops, produces and sells natural botanical and chemical freeze-dried powder injections. It also has freeze-dried powder injection line. Its products include Chinese medicine, biochemical medicine, chemical medicine, cardio-cerebral vascular medicine, digestive system medicine, immune system medicine, vitamins, minerals, enteral and parenteral nutrition.
Executives
Fan Xian E Director
Zhang Cheng Rong Independent director

Kunming Longjin Pharmaceutical Co (SZSE:002750) Headlines

No Headlines